These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6868085)

  • 1. Determinants of resistance to the cardiotoxicity of isoproterenol in rats.
    Joseph X; Bloom S; Pledger G; Balazs T
    Toxicol Appl Pharmacol; 1983 Jun; 69(2):199-205. PubMed ID: 6868085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of myocardial necrosis and cardiac hypertrophy in isoproterenol-treated rats.
    Knufman NM; van der Laarse A; Vliegen HW; Brinkman CJ
    Res Commun Chem Pathol Pharmacol; 1987 Jul; 57(1):15-32. PubMed ID: 2959998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular fibrillation threshold and myocardial cyclic AMP production in rats sensitive or resistant to isoproterenol.
    Joseph X; Jordan AW; Balazs T
    Res Commun Chem Pathol Pharmacol; 1984 May; 44(2):239-49. PubMed ID: 6330819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of isoproterenol-induced myocardial necrosis with 3H-tetracycline.
    Ryan CF; Athari-Nejad A; Holcslaw TL
    Res Commun Chem Pathol Pharmacol; 1979 Sep; 25(3):489-501. PubMed ID: 504787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipolysis is an important determinant of isoproterenol-induced myocardial necrosis.
    Mohan P; Bloom S
    Cardiovasc Pathol; 1999; 8(5):255-61. PubMed ID: 10533957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A temporal profile of changes in myocardial copper after isoproterenol induced cardiac necrosis.
    Mathew BM; Salahuddin ; Ahmad M; Kumar S; Seth TD; Mahdi SQ; Jamil SA
    Jpn Circ J; 1978 Jun; 42(6):695-9. PubMed ID: 713020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental catecholamine-induced myocardial necrosis. I. Morphology, quantification and regional distribution of acute contraction band lesions.
    Todd GL; Baroldi G; Pieper GM; Clayton FC; Eliot RS
    J Mol Cell Cardiol; 1985 Apr; 17(4):317-38. PubMed ID: 3894677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute insulin treatment normalizes the resistance to the cardiotoxic effect of isoproterenol in streptozotocin diabetic rats. A morphometric study of isoproterenol induced myocardial fibrosis.
    Gøtzsche O
    Virchows Arch A Pathol Anat Histopathol; 1985; 405(2):193-201. PubMed ID: 3155884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenylate cyclase activity and localization in necrotic and non-necrotic areas of rat myocardium after injection of high doses of isoproterenol.
    Schulze W; Ostadal B; Pelouch V
    Biomed Biochim Acta; 1984; 43(1):67-75. PubMed ID: 6721878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible protective action of antialdosterone compounds in myocardial necrosis in rats.
    Moudgil LR
    Br J Pharmacol; 1969 Mar; 35(3):558-62. PubMed ID: 5809744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of rats from isoproterenol induced myocardial necrosis by trolnitrate phosphate (Metamine).
    Scriabine A; Stebbins RB
    Experientia; 1966 Feb; 22(2):106-7. PubMed ID: 5927953
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of cordarone on isoproterenol-induced damage to the myocardium in rats.
    Mitova M; Bednarík B; Lupínek Z; Cerný E
    Exp Pathol; 1986; 29(4):217-20. PubMed ID: 3732484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
    Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of acute myocardial lesions by asthma drugs in rats.
    Whitehurst VE; Joseph X; Alleva FR; Vick JA; Whittaker P; Zhang J; Fry BE; Balazs T
    Toxicol Pathol; 1994; 22(1):72-6. PubMed ID: 7915431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental catecholamine-induced myocardial necrosis. II. Temporal development of isoproterenol-induced contraction band lesions correlated with ECG, hemodynamic and biochemical changes.
    Todd GL; Baroldi G; Pieper GM; Clayton FC; Eliot RS
    J Mol Cell Cardiol; 1985 Jul; 17(7):647-56. PubMed ID: 4020881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study of protective effect of tongxinluo capsule on isoproterenol induced myocardial injury in rats].
    Zhao MZ; Liu L; Wang JR
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Jan; 21(1):51-3. PubMed ID: 12577380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of the new calcium antagonist anipamil against isoprenaline-induced cardionecrosis in rats.
    Ciplea AG; Kretzschmar R; Heimann W; Kirchengast M; Safer A
    Arzneimittelforschung; 1988 Feb; 38(2):215-21. PubMed ID: 3130838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomic mechanisms in heart rate variability after isoproterenol-induced myocardial damage in rats.
    Rote WE; Connor JD
    J Auton Nerv Syst; 1992 Apr; 38(1):37-44. PubMed ID: 1588003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a calcium antagonist (D600) on isoprenaline-induced myocardial necrosis in the rat.
    Steen E; Woolf N; Powell T; Rowles PM
    Br J Exp Pathol; 1979 Jun; 60(3):335-9. PubMed ID: 475980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoproterenol induced myocardial necrosis is associated with stress protein synthesis in rat heart and thoracic aorta.
    White FP; White SR
    Cardiovasc Res; 1986 Jul; 20(7):512-5. PubMed ID: 3779748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.